DNA content in cells aspirated from carcinoma of the prostate treated with oestrogenic compounds
- PMID: 524561
- DOI: 10.1007/BF00256602
DNA content in cells aspirated from carcinoma of the prostate treated with oestrogenic compounds
Similar articles
-
Control of response to estramustine phosphate therapy through cytology and DNA analysis of cell nuclei in prospective study.Urology. 1984 Jun;23(6 Suppl):81-8. doi: 10.1016/s0090-4295(84)80105-3. Urology. 1984. PMID: 6730143 No abstract available.
-
Estracyt therapy of advanced prostatic cancer with special reference to control of therapy with cytology and DNA cytophotometry.Eur Urol. 1980;6(2):111-5. doi: 10.1159/000473302. Eur Urol. 1980. PMID: 7358061
-
The oestrogenic effects of ethinyl oestradiol/polyoestradiol phosphate and estramustine phosphate in patients with prostatic carcinoma. A comparative study of oestrogen sensitive liver proteins, gonadotrophins and prolactin.Br J Urol. 1986 Aug;58(4):412-6. doi: 10.1111/j.1464-410x.1986.tb09095.x. Br J Urol. 1986. PMID: 3092893 Clinical Trial.
-
DNA determinations for prognosis and therapy control in prostatic cancer.Semin Oncol. 1983 Sep;10(3 Suppl 3):16-20. Semin Oncol. 1983. PMID: 6364361 Review. No abstract available.
-
Mode of action of estramustine phosphate in hormone dependent and hormone non-dependent prostate cancer.Prog Clin Biol Res. 1985;185A:197-202. Prog Clin Biol Res. 1985. PMID: 3898129 Review. No abstract available.
Cited by
-
Predictive testing in cancer chemotherapy. I. In vivo.Pharm Weekbl Sci. 1985 Jun 21;7(3):93-9. doi: 10.1007/BF01968709. Pharm Weekbl Sci. 1985. PMID: 3895154 Review.
-
Sequential changes of nuclear DNA content caused by chemotherapy in experimental canine gastric cancer.Gastroenterol Jpn. 1985 Dec;20(6):548-57. doi: 10.1007/BF02774814. Gastroenterol Jpn. 1985. PMID: 4085748